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Different pathways activated by morphogens of the early embryonic development, such as
theWnt and the Bone Morphogenetic Protein (BMP) ligands, are involved in diverse phys-
iological and pathological conditions of the nervous system, including neurodegeneration.
In this work, we have analyzed the endogenous activity of the canonical Wnt/β-catenin
and BMP/Smad-dependent pathways in an in vitro model of amyotrophic lateral sclerosis
(ALS), given bymotor neuron-like NSC34 cells stably expressingwild-type or G93Amutated
forms of human Cu/Zn superoxide dismutase-1 (SOD1). As ALS-derived motor neurons,
NSC34 cells expressing mutated hSOD1 show a decreased proliferation rate, are more
susceptible to oxidation-induced cell death and display Golgi fragmentation. In addition,
they display an impaired ability to induce the expression of the motor neuronal marker
Hb9 and, consistently, to morphologically differentiate into a motor neuronal phenotype.
Regarding signaling, our data show that the transcriptional activity associated to theWnt/β-
catenin pathway is decreased, a ﬁnding possibly associated to the cytosolic aggregation of
β-catenin. In turn, the BMP-dependent phosphorylation of Smad1 and the transcriptional
activation of the BMP/Smad pathway is increased in the pathologic model.Together, these
ﬁndings suggest thatWnt/β-catenin and the BMP-dependent pathways could play relevant
roles in the neurodegeneration of motor neurons in the context of ALS.
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INTRODUCTION
Amyotrophic lateral sclerosis (ALS) is a neurodegenerative dis-
ease characterized by the selective degeneration and subsequent
death of motor neurons, those in the motor cortex and brain-
stem (superior motor neurons), as well as the ones located in
the spinal cord (inferior motor neurons; Goodall and Morrison,
2006; Pasinelli and Brown, 2006). Even though most ALS cases
are sporadic, a 5–10% of them have a genetic linkage, as they are
associated to point mutations of several proteins, such as Cu/Zn
superoxide dismutase-1 (SOD1), TAR DNA-binding protein 43
(TDP43), Fused in Sarcoma (FUS), senataxin (SETX), amongst
others (Bruijn et al., 2004; Schymick et al., 2007; Robberecht and
Philips, 2013). Remarkably, a 20% of familial ALS cases have been
linked to point mutations of SOD1 (Rosen, 1993). Indeed, the
G93A mutation of SOD1 has been widely used to generate model
systems of ALS, either animals or in vitro, as they mimic the
main clinical, pathological, and cellular features of the disease
(Gurney et al., 1994; Pasinelli et al., 1998; Arciello et al., 2011).
The mechanisms by which these mutations cause neuronal death
have not been fully described; however, it is believed that rather
than changes in protein activity, conformational changes due to
these mutations lead to the formation of toxic intracellular protein
aggregates (Bruijn et al., 1998; Durand et al., 2006; Bendotti et al.,
2012). In spite of the fact that clinical manifestations of ALS occur
in the adult life, several research lines indicate that alterations of
the motor neuronal network begin at early development of the
nervous system, marking the onset of the disease (Bendotti et al.,
2012; van Zundert et al., 2012; Robberecht and Philips, 2013).
However, the molecular players involved in these early phenotypes
have not been fully described.
Cumulative evidence in the last few years reveals that signaling
pathways triggered by morphogens of the early embryonic devel-
opment, such as theWnt and Bone Morphogenetic Protein (BMP)
families, play key roles on different features of the nervous sys-
tem (Henriquez et al., 2011; Benavente et al., 2012; Henriquez and
Salinas, 2012; Salinas, 2012). Wnt ligands signal through their cog-
nate Frizzled (Fz) receptors to activate several different pathways.
Upon activation of the “canonical”Wnt pathway, the key intracel-
lular effectorβ-catenin escapes proteosomal degradation, becomes
accumulated in the cytosol and traslocates to the nucleus activat-
ing the expression of Wnt target genes (Gordon and Nusse, 2006;
Kim et al., 2009). In addition to its role inWnt signaling, β-catenin
plays crucial roles in cell–cell contacts (Nelson and Nusse, 2004).
In turn, BMP ligands bind to pre-formed heteromeric complexes
of BMP receptors type I and type II (BMPRI and BMPRII) to
induce the phosphorylation of the cytosolic Smad proteins that
migrate to the nucleus to induce target genes (Nohe et al., 2002;
Shi and Massague, 2003; Miyazono et al., 2005). In addition,
BMPs also have the ability to trigger Smad-independent path-
ways (Sieber et al., 2009; Bragdon et al., 2011). Signaling through
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Wnt and BMP ligands exert a wide range of effects that are highly
dependent on the cell type; therefore, indentifying critical factors
such as co-receptors, antagonists and intracellular regulatory pro-
teins, is required to understand the potential contribution of these
signaling pathways in different physiological contexts.
Wnt pathways are not only involved in the formation of neu-
ronal connectivity, but also in synaptic function and plasticity
(Cerpa et al., 2011; Salinas, 2012). Remarkably, several lines of
research support the idea that a decrease inWnt signaling activity is
associated to the pathogenesis of someneurodegenerative diseases,
such as Alzheimer’s and Parkinson’s (Inestrosa and Arenas, 2010;
L’Episcopo et al., 2011). Consistent with this notion, activation of
Wnt signaling plays neuroprotective roles inmodels of Alzheimer’s
disease, either in vivo or in vitro (De Ferrari et al., 2003; Alvarez
et al., 2004; Cerpa et al., 2010; Purro et al., 2012). In this regard,
recent evidence shows that some Wnt ligands are up-regulated in
motor neurons of ALS model mice (Chen et al., 2012; Li et al.,
2013; Wang et al., 2013). Regarding BMP-dependent signaling, it
has been demonstrated that the BMP2 ligand is up-regulated in
damaged motor axons of the facial nerve, suggesting that changes
in the activity of BMP pathways could be involved in protection
or regeneration of motor neurons (Wang et al., 2007; Henriquez
et al., 2011).
In this work, we ﬁrst characterized motor neuron-like NSC34
cells stably expressingwild-type orG93Amutated forms of human
SOD1 (Gomes et al., 2008). ALS-like cells displayed Golgi frag-
mentation, as well as impaired morphological differentiation and
lower expression levels of the motoneuron marker Hb9 than
control cells. Also, cell death was signiﬁcantly higher in differ-
entiated cells expressing mutant hSOD1. Regarding signaling,
Wnt-dependent transcription was inhibited in these cells, a ﬁnd-
ing likely associated to an altered distribution of β-catenin. In
turn, the BMP/Smad-dependent pathway was increased in ALS-
like cells. Our ﬁndings suggest that Wnt and BMP-dependent
pathways could play relevant functions in the context of motor
neuronal cell death occurring in ALS.
MATERIALS AND METHODS
CELL CULTURE
Neuroblastoma × spinal cord cells NSC34 (Cashman et al., 1992)
stably expressing human wild-type SOD1 (NSC34hSOD1WT
cells) or mutant SOD1 (NSC34hSOD1G93A cells) were a gen-
tly gift of Dr. Julia Costa at ITQB, Oerias, Portugal (Gomes et al.,
2008). Cells were grown in Dulbecco’s modiﬁed Eagle’s medium
(DMEM; Hy-Clone, South Logan, UT, USA) supplemented with
15% fetal bovine serum (FBS) 1% penicillin/streptomycin solu-
tion and 0.4 mg/ml G418 at 37◦C in a 5% CO2 atmosphere. Cells
were grown on plastic or glass surfaces previously coated with
0.01% poli-L-lysine (Sigma Aldrich, Saint Louis, MO, USA) for
24 h at 37◦C, and 0.5% gelatin (Sigma) for 30 min at 37◦C. Cells
were induced to differentiate in Neurobasal medium (Invitrogen,
Grand Island, NY, USA) without FBS for 24–36 h.
REVERSE TRANSCRIPTION-POLYMERASE CHAIN REACTION
Total RNA from NSC34 cells was obtained using Trizol reagent
(Invitrogen). For reverse transcription-polymerase chain reaction
(RT-PCR), 1 μg of RNA was pretreated with DNase I (Fermen-
tas, ON, Canada) and further incubated in a buffer containing
10 μM oligo dT, reverse transcription buffer (0.5 M Tris–HCl, pH
8.3, 0.75 M KCl, 0.03 M MgCl2), 20 U RNase inhibitor (NEB,
Ipswich, MA, USA) and 1 mM dNTPs (Invitrogen) at 37◦C for
5 min. Stratascript reverse transcriptase (Stratagene, Baltimore,
MD, USA) was added (160 U) and the mix was further incubated
at 42◦C for 1 h. Parallel reactions were performed in the absence
of reverse transcriptase to control for the presence of contam-
inant DNA. For ampliﬁcation, a cDNA aliquot in a volume of
12.5 μl containing 20 mM Tris buffer pH 8.4, 50 mM KCl, 1.6 mM
MgCl2, 0.4 mM dNTPs, and 0.04 U Taq polymerase (Kapabiosys-
tems, Boston, MA, US) was incubated 95◦C for 5 min, 95◦C for
30 s, 50◦C for 30 s, and 72◦C for 30 s for 35 cycles. Primers were
Hb9_S: GTACCTGTCTCGACCCAAGC, Hb9_AS: CCATTGCT-
GTACGGGAAGTT (expected product 327 bp), GAPDH_S:
GGAGCCAAACGGGTCATCATCTC, GAPDH_AS: GAGGGGC-
CATCCACAGTCTTCT (expected product 233 bp) BMPRII_S:
TTTGCAGCCTGTGTGAAGTC, BMPRII_AS: CACAAGCTC-
GAATCCCTAGC (expected product 403 bp). PCR products were
separated by 1.2% agarose gel electrophoresis and visualized
following ethidium bromide staining.
WESTERN BLOT
Cells were lysed in Tris-HCl 50 mM, pH 7.5; NaCl 100 mM,Triton
X-100 0.5 % v/v buffer. Equal amounts of protein were resolved
on SDS-polyacrylamide gels, transferred onto PVDF membranes
(Millipore, Billerica, MA, USA) and subjected to Western blot
analyses. Antibodies against α-tubulin (Sigma-Aldrich, St. Louis,
MO, USA), Id1 (Santa Cruz Biotechnology, Santa Cruz, CA,
USA), β-Catenin (Santa Cruz), phospho-Smad 1/5/8 (pSmad)
(Cell Signaling Technologies, Frankfurt, Germany), and Hb9
(Abcam, Cambridge, UK) were used for immunoblotting. Bound
antibodies were visualized using horseradish peroxidase-coupled
secondary antibodies (Jackson InmunoResearch, West Grove, PA,
USA) followed by development under a chemiluminescence kit
(Perkin Elmer, Waltham, MA, USA).
IMMUNOFLUORESCENCE MICROSCOPY
For immunostaining, NSC34 cells were grown on 18 mm glass
coverslips. When indicated, cells were treated with 40 mM
lithium chloride for 6 h. The medium was removed and cells
were rinsed with cold PBS, ﬁxed with 4% paraformaldehyde for
30 min, or acetone/methanol (1:1) for 5 min, at 4◦C and subse-
quently permeabilized with 0.1% Triton X-100 in Tris-phosphate
buffer. Cells were rinsed with Tris-phosphate and then incu-
bated with primary antibodies diluted in blocking solution (1%
BSA in Tris-phosphate buffer), 15 h at 4◦C. Primary antibodies
were anti-Islet1 (1:10; Developmental Studies Hybridoma Bank);
anti-MAP1B (1:450; Santa Cruz); anti-β-Catenin (1:200; Santa
Cruz), and anti Hb9 (1:100; Abcam). Corresponding Alexa-488
and -546 conjugated secondary immunoglobulins (Invitrogen)
were incubated for 2 h at room temperature. Images were
acquired with a laser confocal LSM700 Zeiss microscope at the
CMA Bio–Bio facility (Universidad de Concepción, Concepción,
Chile).
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TRANSIENT TRANSFECTION
Cells were incubated in OptiMEM medium (Invitrogen) and
transfected using a Lipofectamine and Plus Reagent mix (Invit-
rogen), according to the indications of the manufacturer. For
different luciferase reporter assays, the amounts of plasmid DNAs
were: pId1-luc (Lopez-Rovira et al., 2002) 1.8 μg, pRL-SV40
180 ng, and TOPFlash 0.7 μg, pRL-SV40 70 ng. To determine
the morphology of the Golgi apparatus, cells were transfected
with 700 ng the FU-GolgimRFP plasmid, coding for the Golgi
β-galactosiltransferase protein fused to red ﬂuorescent protein (a
gently gift of Dr. P. Zamorano, Universidad deAntofagasta, Chile).
LUCIFERASE ASSAYS
Transfected cells in 35 mm plates were split 24 h after transfection
and induced to differentiate in serum free Neurobasal medium for
the indicated times. Luciferase activity was quantiﬁed using the
Luciferase Assay System (Promega, Madison, WI, USA). Results
were normalized against aRenilla luciferase control reporter vector
(Promega).
CELL VIABILITY ASSAY
Cells grown in 35 mm plates were treated with 0.2 mM hydrogen
peroxide for 30 min at 37◦C. After washing, cells were incubated
with growing or differentiation medium and returned to the incu-
bator for additional 6 h. Cell viability was measured by the LDH
release assay based on the instructions of the manufacturer (VAL-
TEK, Santiago, Chile). LDH activity was quantiﬁed in conditioned
media and in cell extracts obtained in buffer Tris-HCl 50 mM, pH
7.5, NaCl 100 mM, Triton X-100 0.5% v/v, at the indicated times.
ADHESION ASSAY
Cell culture substrates were prepared by coating Petri plates
with nitrocellulose by dissolving 5 cm2 of nitrocellulose in 6 ml
of methanol (Lagenaur and Lemmon, 1987). Droplets of 2 μl
containing substrates were applied. Substrates were 3.6 mg/ml col-
lagen, 1%gelatin, 2mg/ml poli-L-lysine, 1mg/ml laminin (Sigma).
After 1 h at 37◦C, plates were washed and subsequently blocked
with 1 % BSA. Cells were added and incubated for 2 h at 37◦C.
After washing, bound cells were ﬁxed with 4% paraformaldehyde
for 30 min at 4◦C. Images were acquired with an Olympus CK40
microscope.
PROLIFERATION ASSAY
Plastic 35mmplateswere seededwith 250,000 cells and trypsinized
every day for three consecutive days. Cells were manually counted
with a hemacytometer using an Olympus CK40 microscope.
Results correspond to the average ± SEM of three independent
experiments.
IMAGE ANALYSIS
Acquired images were analyzed using the ImageJ software. The
number of differentiated cells and the length of their neurites were
determined in cells having at least oneneuritewith aminimumsize
equal to the cell soma diameter. For each condition, 20–25 ﬁelds
fromthreedifferent experimentswere evaluated. Themean±SEM
intensity was plotted.
STATISTICAL ANALYSIS
One-way ANOVA was used for comparison among three or more
groups followedbyBonferroni’s post hoc analysis formultiple com-
parison between different groups. Neurite length and TOPFlash
activity were compared using unpaired t-test. p < 0.05 was
considered to indicate statistical signiﬁcance.
RESULTS
CULTURE CONDITIONS FOR NSC34hSOD1 CELLS
As NSC34 cells stably expressing human SOD1, either the wild-
type or the G93A mutated form, adhere poorly to plastic or
glass culture surfaces, we ﬁrst searched for a homogeneous and
reproducible surface coating that allows good cell adhesion and
differentiation. We begun evaluating commonly used coating sub-
strates for cell adhesion such as gelatin, collagen, and poly-L-lysine,
using bovine serum albumin and laminin as negative and positive
controls, respectively. Quantiﬁcation of the data shows that poly-
L-lysine and gelatin were the best substrate of the series, as they
allowed the adhesion of signiﬁcantly higher amounts of cells than
the control BSA (see table in Figure 1A). As we observed that cells
seeded on poly-L-lysine showed a round and refringent aspect,
whereas cells on gelatin assumed a ﬂattened polygonal morphol-
ogy (see table in Figure 1A), we tested mixtures of substrates.
Figure 1 (two lower panels) shows that cells seeded on a surface
containing poly-L-lysine plus gelatin adhered in suitable number
and morphology, as compared to cells plated onto poly-L-lysine
alone (Figure 1, two upper panels). In addition, we found that
cells seeded on poly-L-lysine plus gelatin also displayed better
morphological differentiation than cells plated on poly-L-lysine
alone, characterized by cells extending processes which origin and
end are clearly distinguishable (Figure 1, 24 h). This morpholog-
ical feature was better observed after decreasing the amount of
plated cells (Figure 1, lowest panel). In summary, we setup opti-
mal conditions for the ampliﬁcation, adhesion, and differentiation
of NSC34hSOD1 cells.
NSC34hSODG93A CELLS AS A MODEL OF ALS MOTOR NEURONS
We next conducted a series of experiments aimed to assess the
reliability of NSC34hSOD1 cells to be used as a model of ALS
motor neurons. First, we evaluated the effect of the stable expres-
sion of hSOD1 on cell proliferation by counting the number of
cells seeded onto uncoated plastic dishes every 24 h. While both
NSC34hSOD1 cell lines grow 0.5-fold during the ﬁrst 48 h, only
NSC34hSOD1WT cells continued proliferating at 72 h (2.01 ± 0.1
times, compared to 24 h; ∗∗p < 0.05). Indeed, the number
of NSC34hSODG93A cells remained constant and was signiﬁ-
cantly lower than NSC34hSOD1WT cells at the same time point
(Figure 2A), revealing that the stable expression of hSODG93A
results in an impaired proliferation rate of NSC34 cells.
Second, considering that ALS cells are more sensitive to oxida-
tive stress than controls (Wijesekera andLeigh,2009),we evaluated
the survival of NSC34hSOD1 cells in basal and oxidative condi-
tions (0.2 mM hydrogen peroxide) by quantifying LDH activity
in conditioned media and extracts of both cell lines. In basal
conditions, cell survival was not different in growing and dif-
ferentiated conditions of both cell lines (Figure 2B). However,
exposure to an oxidative condition induces a strong increase in
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FIGURE 1 | PLL/gelatin coating is a good adhesion and
differentiation substrate for NSC-hSOD1 cells. NSC34hSOD1 cells
bind to different adhesion substrates. (A) Culture dishes were coated
with methanol-solubilized nitrocellulose. Droplets containing collagen,
gelatin, PLL, BSA, and laminin were applied to the surface of the
dishes and dried. NSC34hSOD1 cells were then incubated for 2 h and
examined by phase contrast microscopy. Table represents the
average ± SEM of three independent experiments (∗p < 0.05,
∗∗p < 0.001, ∗∗∗p < 0.001, ANOVA) as well as a morphological
evaluation of the adhesion. (B) Culture dishes were coated with the
indicated concentrations of PLL for 24 h. When indicated, gelatin was
added for 30 min. Cells were allowed to adhere for 36 h, and
differentiated for additional 24 h and analyzed by phase contrast
microscopy. A total of 60,000 cells were seeded in every condition,
except for the lowest panel pictures, where the number was diminished
to 40,000 cells. Bar, 50 μm.
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LDH release of differentiated NSC34hSODG93A cells compared
to those cultured in growing conditions; indeed, extracellular LDH
is signiﬁcantly higher in differentiated NSC34hSODG93A than
control NSC34hSODWT cells (Figure 2C). Thus, NSC34 cells
expressing hSODG93A are more susceptible to oxidation-induced
cell death.
Third, we considered thatALS motor neurons display fragmen-
tation of their Golgi apparatus (Mourelatos et al., 1994; Turner
et al., 2005; Gomes et al., 2008; Sundaramoorthy et al., 2013).
In order to determine the temporal appearance of Golgi dis-
ruptions, cells were transfected with a plasmid coding for a
β-galactosyltransferase fused to mRFP and subsequently differ-
entiated. In NSC34hSOD1WT cells, the Golgi staining distributes,
as expected, in the periphery of the nucleus, either in undifferenti-
ated cells as well as in those differentiated for 24 h (Figure 3).
Remarkably, even though the labeling also distributes in the
perinuclear region of undifferentiated NSC34hSOD1G93A cells,
Golgi portions are also disseminated within cytoplasmic regions
(Figure 3). In differentiated NSC34hSOD1G93A cells, Golgi frag-
ments were not concentrated in any particular subcellular region
and appear regularly distributed within the cytoplasm (Figure 3).
Taken together, our results show NSC34hSOD1 cells phenocopy
what has been observed in patients as well as in validated models
of ALS. Also, they suggest that Golgi disruption could be an early
event of ALS pathogenesis.
Fourth, we evaluated the ability of NSC34hSOD1 cells to dif-
ferentiate into a neuronal-like phenotype (Figure 4). Cells were
seeded onto coated glass coverslips, differentiated for 24 h and sub-
sequently stained against MAP1B (Benavente et al., 2012). Even
though both cell lines extend neurites after 24 h, this feature is
impaired in NSC34hSODG93A cells (see Figures 1 and 4A, lowest
panel). Indeed, quantiﬁcation of the data reveals an expected sig-
niﬁcant increase of NSC34hSOD1WT cells bearing neurites upon
differentiation (from 12.1 ± 7.1 to 54.0 ± 6.7%; ∗∗p< 0.01), while
the proportion of NSC34hSOD1G93A cells having neurites was
not signiﬁcantly higher than undifferentiated cells (Figure 4B).
Similarly, the average length of the neurites was higher in control
NSC34hSOD1WT than in NSC34hSOD1G93A cells, either before
(77.4 ± 4.9 vs. 66.8 ± 6.4 μm; ∗p< 0.05) and after differentiation
(95.3 ± 10.3 vs. 76.6 ± 7.5 μm; ∗p < 0.05; Figure 4C). These
results suggest that the constitutive expression of hSOD1G93A
impairs the ability of NSC34 cells to differentiate.
Our ﬁndings thus far show that several features of the phys-
iopathology of ALS are evident at particular time points of the
differentiation of NSC34hSOD1 cells. Even though NSC34 cells
have been extensively used as a valid model of motor neurons
(Cashman et al., 1992), their molecular identity has not been fully
described. In this context, we ﬁrst analyzed the expression of
Islet-1, a transcription factor early expressed and necessary for
the differentiation of motor neurons (Ericson et al., 1992; Pfaff
et al., 1996). Immunocytochemical analyses showed that Islet-
1 is constitutively expressed in both cell lines, in growing and
differentiated conditions, and becomes mainly concentrated in
the cell nuclei (Figure 5A), suggesting that the early commit-
ment of NSC34 cells to the motor neuron phenotype is not
affected by the stable expression of hSOD1. We then followed
the expression of Hb9, a transcription factor selectively expressed
FIGURE 2 | NSC34-hSOD1G93A cells proliferate less efficiently and are
more susceptible to oxidation-induced cell death. (A) Cells were
seeded in p35 plastic dishes and kept in growing medium for up to 72 h.
Cells were tripsinized every 24 h and counted. Plot represents the
average ± SEM of three independent experiments performed by triplicate
(∗∗p < 0.001, ANOVA). (B,C) NSC34-hSOD1 cells were seeded in
PLL/gelatin-coated plastic dishes and differentiated (B) or treated with
H2O2 and differentiated (C). Plots represent the ratio of LDH concentration
in conditioned media against that in cell extracts, and is the average ± SEM
of three experiments (∗p < 0.05, ANOVA).
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FIGURE 3 | NSC34hSOD1G93A cells display Golgi disruption.
NSC34hSOD1 cells were transfected with the FU-Golgi-mRFP vector,
and ﬁxed at 0 and 24 h of differentiation to determine the
subcellular localization of Golgi fragments. Immunocytochemistry
against MAP1B was used to stain the cell cytoplasm and nuclei
counter staining Topro-3. Bar, 20 μm.
by developing motor neurons (Pfaff et al., 1996). Hb9 expression
sufﬁces to induce the differentiation of post-mitotic cells, whereas
its absence results in misslocalized motor axons in distal muscle
regions (Arber et al., 1999). PCR analyses showed that the expres-
sion of Hb9 mRNA is increased at 24 h of the differentiation
of NSC34hSOD1WT cells, but not in NSC34hSOD1G93A cells
(Figure 5B). These results were corroborated at the protein level
following Western blot analyses (Figure 5C). Quantiﬁcation of
the data reveals that Hb9 expression is signiﬁcantly higher in dif-
ferentiated NSC34hSOD1WT, compared to NSC34hSOD1G93A
cells (Figure 5C, lower panel). Consistent with these ﬁndings,
our immunocytochemical analyses showed that, even though all
cells distribute Hb9 in the nucleus, the intensity of the staining is
reduced in differentiated NSC34hSOD1G93A cells (Figure 5D).
These ﬁndings suggest that an ALS condition could interfere with
the ability of neuronal precursors to acquire the motor neuronal
fate during early embryonic development.
Wnt- AND BMP-DEPENDENT SIGNALING IN NSC34hSOD1WT AND
NSC34hSODG93A CELLS
Disfunction of Wnt signaling has been associated to neu-
rodegenerative conditions such as Alzheimer’s and Parkinson’s
disease (Inestrosa and Arenas, 2010; L’Episcopo et al., 2011;
Marchetti et al., 2013). More recently, the expression lev-
els of mRNAs coding for proteins related to Wnt signaling
have also been proven to be altered in mouse models of
ALS (Yu et al., 2013).
We ﬁrst analyzed the transcriptional activation of the Wnt/β-
catenin pathway following the activity of a Wnt reporter gene.
Our ﬁndings show a signiﬁcant increase during the differentia-
tion of control NSC34hSOD1WT cells, whereas such activation
was not observed in NSC34 cells expressing the G93A mutation
of hSOD1 (Figure 6A). Based on these ﬁndings, we next stud-
ied the expression proﬁle of the key Wnt mediator β-catenin.
Western blot analyses showed that the total amount of β-catenin
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FIGURE 4 | A small proportion of NSC-hSOD1G93A cells display neurite
outgrowth. NSC34hSOD1WT and NSC34hSOD1G93A cells were plated in
PLL/gelatin-coated coverslips and differentiated for 24 h. Cells were ﬁxed and
stained against MAP1B (A). Different parameters of morphological
differentiation, including percentage of cells with or without neurites (B) and
average neurite length (C) were measured using ImageJ. Plots are the
average ± SEM of three independent experiments (∗∗p < 0.01, ANOVA;
∗p < 0.05, t test). Bar, 50 μm.
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FIGURE 5 | Expression of motor neuron cell markers in NSC34hSOD1
cells. (A) NSC34hSOD1 cells were seeded onto glass coverslips and
differentiated for 24 h. Immunocytochemical analyses show that Islet-1 is
localized at the cell nuclei, which were counterstained with ToPro-3. (B)Total
RNA was extracted at 0 and 24 h of NSC34hSOD1 cell differentiation, and
subsequently subjected to reverse transcription (RT+) to obtain cDNA. As a
control, the same reaction was performed in the absence of reverse
transcriptase (RT−). PCRs were performed with speciﬁc primers to amplify
Hb9 and the internal control GAPDH. (C)Western blot analyses were
performed with speciﬁc antibodies against Hb9 and the internal control
α-tubulin. The bottom panel shows quantiﬁcation of the data, which is
expressed as the mean ± SEM of four independent experiments (*p < 0.05).
(D) Immunocytochemical analyses show that Hb9 is localized in the nuclei of
all cells, but the intensity of the staining is less evident in differentiated
NSC34hSOD1G93A cells. Cells were also stained with MAP1B and nuclei
with ToPro-3. Bar, 20 (A) and 50 μm (D).
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was not signiﬁcantly modiﬁed during the differentiation of both
NSC34hSOD1 cell lines (Figure 6B). Next, we analyzed the dis-
tribution of β-catenin following activation of the pathway with
lithium chloride (Alvarez et al., 2004). The intensity of nuclear β-
catenin staining becomes strongly increased in the control cell
line upon lithium treatment, being more evident in differen-
tiated cells (Figure 6C). In turn, the localization of β-catenin
in the nuclei of ALS-like cells was virtually absent in undiffer-
entiated cells and very faint in differentiated ones (Figure 6C).
Nevertheless, the distribution of β-catenin in the cytoplasm dis-
played pronounced modiﬁcations. In control cells most β-catenin
is found in focal points of cell–cell contacts, either in differenti-
ation and growing conditions. In turn, these structures are more
abundant and larger in NSC34hSOD1G93A cells, a feature that
is particularly evident in undifferentiated cells (Figures 6C,D). In
isolated cells, aggregates of cytosolic β-catenin were only detected
inNSC34hSOD1G93A cells (arrows in Figure 6D). Together, these
ﬁndings suggest that canonical Wnt signaling is impaired in ALS-
like cells, possibly due to the altered distribution of the key effector
β-catenin.
Our recent ﬁndings show that BMP-dependent pathways could
play relevant roles on the differentiation of motor neurons
(Benavente et al., 2012). As a ﬁrst hint to analyze BMP signaling
in the context of ALS, we studied the expression of the mRNA
coding for the type II BMP receptor (BMPRII), which signals
through either Smad and non-Smad pathways (Sieber et al., 2009;
Henriquez et al., 2011). Our results show that BMPRII expression
was notmodiﬁed during the differentiation of bothNSC34hSOD1
cells, as compared to the internal control GAPDH (Figure 7A).
Next, we performed western blot analyses to detect the phos-
phorylation of Smad1/5/8, a crucial step in the activation of the
Smad-dependent BMP pathway (Henriquez et al., 2011). Simi-
lar to our previous ﬁndings in parental NSC34 cells (Benavente
et al., 2012), pSmad is down-regulated during the differentia-
tion of both NSC34hSOD1 cells; however, pSmad basal levels
are signiﬁcantly higher in undifferentiated NSC34hSODG93A
cells, compared to controls (Figure 7B). Then, in order to
correlate pSmad levels with BMP-dependent transcription, we
analyzed the expression and activity of the Smad-dependent early
responsive gene Id1, a negative regulator of the differentiation
of neurogenic precursors (Ying et al., 2003; Vinals et al., 2004).
Immunodetection experiments showed that Id1 levels in undiffer-
entiated cells were signiﬁcantly higher in NSC34hSOD1G93A cells
compared to controls, whereas its expression is similarly down-
regulated during the differentiation of both cell types (Figure 7C).
Finally, we transiently transfected undifferentiated NSC34hSOD1
cells with a luciferase Smad-responsive Id1 reporter gene
(Lopez-Rovira et al., 2002). Consistent to our ﬁndings on pSmad
and Id1 expression levels, Figure 7D shows that the basal Id1-
dependent transcription is twofold higher in NSC34hSOD1G93A
cells compared to control NSC34hSOD1WT cells, whereas this
activity is strongly diminished after 24 and 48 h of differentiation
in both cell types. Together, these ﬁndings support the notion
that BMP/Smad signaling varies inversely with motor neuron
differentiation; in addition, they also suggest that this signaling
pathway could be up-regulated in ALS motor neuron precursor
cells.
DISCUSSION
Amyotrophic lateral sclerosis is a neurodegenerative disease that
leads to progressive paralysis and death after around 4 years from
the onset of the disease. Since its approval, the only treatment
for ALS is Riluzole, a drug that inhibits the release of glutamate
by inactivation of voltage-sensitive sodium channels (van Zundert
et al., 2012), extending 3months on average. Therefore, it is critical
to generate model systems to describe the physiopathology of the
disease and where to assess more effective therapeutic alternatives.
Because of its origin, NSC34 cells exhibit several features of
motor neurons (Cashman et al., 1992), and are a more suit-
able in vitro model to study ALS than other neuronal cell
lines that have also been used for similar analyses such as the
Neuro-2a and SH-SY5Y cells (Pasinelli et al., 1998; Arciello et al.,
2011). In their initial characterization, both NSC34hSOD1 cell
types adhered well to Matrigel/poly-D-lysine matrices (Gomes
et al., 2008). As Matrigel contains most of the components
of the extracellular matrix, likely inﬂuencing cell behavior
(Hughes et al., 2010; Ventre et al., 2012), we looked for simpler
coating molecules. We found that that the poly-L-lysine plus
gelatin mixture allowed good cell adhesion and differentiation of
NSC34hSOD1 cells. In agreement with our results, both poly-L-
lysine and gelatin have been extensively used by their ability to
signiﬁcantly increase cell adhesion in various cell types while not
affecting cell proliferation or differentiation (Alvarez Perez et al.,
2012; Kuo and Chung, 2012).
Several molecular mechanisms are likely to converge to allow
motor neuronal degeneration, the main feature of ALS (Pasinelli
and Brown, 2006; Wijesekera and Leigh, 2009; Gordon and
Meininger, 2011; Bendotti et al., 2012). In this regard, our
results revealing that NSC34hSOD1G93A cells are more prone to
oxidation-induced cell death are supported by previous ﬁndings
showing that NSC34 cells expressing hSOD1G93A increase reac-
tive oxygen species production, while decreasing their viability (Li
et al., 2003). In addition, other detrimental stimuli, such as stau-
rosporine treatment, induced the death of NSC34hSOD1G93A
cells (Gomes et al., 2008), reinforcing the notion that the expres-
sion of mutant SOD1 increases the vulnerability of motor neurons
to cell damage.
Another hallmark of ALS neuropathology is the fragmenta-
tion of their Golgi apparatus, a feature that has been observed
in ALS patients (Mourelatos et al., 1994), as well as in various
model systems, such as NSC34 cells expressing or treated with
hSOD1G93A (Mourelatos et al., 1994; Gomes et al., 2008), and
transgenic mice expressing hSOD1G93A (Turner et al., 2005).
Interestingly, our present ﬁndings reveal that Golgi fragmentation
occurs prior to neuronal differentiation. In this regard, it has been
shown that mutated hSOD1 is released from NSC34hSOD1G93A
cells, as well as from primary astrocyte cultures derived from
hSOD1G93A transgenic mice, via exosomes (Gomes et al., 2007;
Basso et al., 2013). These vesicles are then endocytosed by
neuronal cells inducing Golgi fragmentation (Sundaramoorthy
et al., 2013). Considering these previous ﬁndings supporting
the notion that ALS-inducing stimuli could be spread between
cells, our present results strongly suggest that such mechanism
could take place from early steps of the pathogenesis of the
disease.
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FIGURE 6 |TheWnt/β-catenin signaling increases in control
NSC34hSOD1WT cells but not in ALS-like NSC34hSOD1G93A cells,
possibly due to the presence of β-catenin aggregates. (A) Cells were
seeded on PLL/gelatin-coated dishes and transfected with theWnt reporter
TOPFLASH vector plus the pRLSV40 Renilla control plasmid, and
subsequently differentiated for the indicated times. The graph shows the
normalized reporter gene activity (luciferase/Renilla). Data are expressed as
the average ± SEM of three independent experiments performed by
quadruplicate (∗p < 0.05, paired t test). (B)Total protein extracts were
obtained from differentiating NSC34hSOD1 cells at 0, 24, and 36 h and were
subjected to western blot analyses using an anti β-catenin antibody. An anti
α-tubulin antibody was used as loading control. The graph shows the
quantiﬁcation of β-catenin normalized to α-tubulin bands, and represent the
average ± SEM of three independent experiments. (C) Undifferentiated and
differentiated NSC34hSOD1 cells were treated with 40 mM lithium chloride
for 6 h and stained with an anti β-catenin antibody. Lithium treatment
increases the nuclear staining of β-catenin in control cells, a feature that is not
evident in ALS-like cells. (D) NSC34hSOD1 cells were ﬁxed before and after
24 h of differentiation and subsequently subjected to immunocytochemical
analyses using an anti β-catenin antibody. Grouped and isolated cells are
shown for each condition. Nuclei were counterstained with ToPro-3. Bar, 20
(C) and 10 μm (D).
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FIGURE 7 | Undifferentiated NSC34hSOD1G93A cells display
increased activity of the BMP/Smad signaling pathway. (A) Total
RNA was obtained from NSC34hSOD1 cells at 0 and 24 h of
differentiation and BMPRII mRNA levels were analyzed by RT-PCR. As
loading control GAPDH was ampliﬁed. Negative control reactions
without reverse transcriptase (RT−) are also shown. (B,C) Western
blot analysis using anti pSmad (B) or anti Id1 (C) antibodies in
protein extracts of NSC34hSOD1 cells obtained at the indicated times
of differentiation. Anti α-tubulin was used as loading control. Data
analyses of band intensities are expressed as the mean ± SEM of
three independent experiments (∗p < 0.05; ∗∗∗p < 0.01). (D) NSC-34
cells were transfected with an Id1 promoter luciferase (Luc) reporter
gene. Enzyme activity was measured before or after 24 and 36 h of
differentiation and normalized by Renilla (Ren) luciferase activity. Data
are the mean ± SD of three independent experiments performed in
quadruplicate (∗p < 0.05).
Consistent with previous ﬁndings showing that NSC34 cells
expressing hSOD1G93A display impaired morphological differ-
entiation (Gomes et al., 2008; Magrane et al., 2009), and decreased
expression of the neuronal marker MAP2 (Lee et al., 2002), our
data show that these cells have a lower percentage of differentiated
cells that bear shorter neurites than controls.What is themolecular
mechanism underlying this altered phenotype? Even though
NSC34 cells were obtained from neuronal precursors from the
spinal cord, and have been validated as a cholinergic system
(Cashman et al., 1992; Maier et al., 2013), their identity as motor
neurons has not been evaluated in detail. Islet-1 is considered
an early marker of differentiation of motor neurons and their
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absence impairs the ability of neuronal precursors to differentiate
into motor neurons (Pfaff et al., 1996). In turn, Hb9 is a tran-
scription factor expressed in post-mitotic motor neurons, which
suggest that it functions later in the differentiation process (Pfaff
et al., 1996; Tanabe et al., 1998). Our ﬁndings show that control
cells display a constitutive expression of Islet-1 and induce the
expression of Hb9 upon differentiation; however, whereas Islet-
1 levels are similar in both cell lines, the expression of Hb9 is
signiﬁcantly impaired in ALS-like cells, indicating that the consol-
idation of motor neuronal identity might be compromised. In this
regard, recent evidence show that motor neuron-like cells driven
from iPS cells obtained from hSOD1G93A mice express several
motor neuronmarkers, such as choline acetyl transferase andHb9,
and exhibit shorter neuronal projections than cells derived from
control mice (Yao et al., 2013).
Several lines of research support the idea that a decrease
in Wnt signaling activity is associated to the pathogenesis of
some neurodegenerative diseases, such as Alzheimer’s and Parkin-
son’s (Inestrosa and Arenas, 2010; L’Episcopo et al., 2011). When
hippocampal neurons are treated with the Aβ peptide (which
extracellular accumulation is a hallmark of Alzheimer’s disease),
there is an increase in cell apoptosis as well as in GSK-3β activity,
whereas the intracellular levels of β-catenin and the transcrip-
tion of Wnt-target genes are reduced (Garrido et al., 2002; De
Ferrari et al., 2003; Alvarez et al., 2004). Consistent with this
notion, activation of Wnt signaling plays neuroprotective roles
in models of Alzheimer’s disease either in vivo or in vitro (De
Ferrari et al., 2003; Alvarez et al., 2004; Cerpa et al., 2010; Purro
et al., 2012). Indeed, the treatment of hippocampal slices with
antibodies against the Wnt inhibitor DKK1 reverts the adverse
effects observed in AD brains (De Ferrari et al., 2003; Alvarez et al.,
2004; Cerpa et al., 2010; Purro et al., 2012). Together, these ﬁnd-
ings provide a strong support to a crucial role forWnt signaling on
neurodegeneration.
Recent ﬁndings show that the motor neurons of ALS model
mice display altered expression of some Wnt effectors, such as
Wnt1, Wnt2, Wnt5a, Fz1, and Fz2 (Chen et al., 2012; Li et al.,
2013; Wang et al., 2013). Consistently, following a systematic
microarray approach, Yu et al. (2013) have shown that many
Wnt effectors, including Wnt ligands, Fz receptors, endoge-
nous antagonists, downstream effectors, and target genes modify
their expression in the spinal cord of ALS mice. Remarkably,
when we analyzed Wnt signaling, we found that the ALS-like
motor neurons did not activate the β-catenin-dependent Wnt
pathway during their differentiation, as we observed in control
cells.
Neurodegenerative diseases are characterized by the forma-
tion of toxic protein aggregates, either because they block cell
functions or because they sequester other proteins (Wood et al.,
2003; Bergemalm et al., 2010). In in vitro models of Alzheimer’s
disease, activation of the Wnt pathway with lithium chloride
results in an increase in total β-catenin levels (De Ferrari et al.,
2003; Alvarez et al., 2004), as well as in increased neuronal sur-
vival (De Ferrari et al., 2003). Our present ﬁndings show that
lithium treatment induced the localization of β-catenin in the
nuclei of control cells, whereas this staining was signiﬁcantly
reduced in cells expressing mutated hSOD1. Remarkably, the
intracellular distribution of β-catenin was notoriously affected,
FIGURE 8 |Working model for Wnt and BMP pathways as
potential mediators of ALS pathogenesis. Wnt and
BMP-dependent signaling pathways display opposite alterations at
different stages of the development of ALS motor neurons. Based
on our present ﬁndings we propose that BMP/Smad signaling is
up-regulated at early stages of the differentiation of ALS motor
neurons. In turn, the differentiated cells display an impaired ability to
activate Wnt/β-catenin signaling.
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evidenced by the presence of intracellular aggregate-like structures
in cell–cell contacts of NSC34hSOD1G93A cells. Interestingly,
aggregates of β-catenin have been detected in in vitro mod-
els of AD (Ghanevati and Miller, 2005). Also, β-catenin is
slightly detected in hSOD1-containing hyaline inclusions in the
spinal cord of ALS model mice (Zhang et al., 2006). Therefore,
it is plausible to interpret our ﬁndings as that the abnormal
distribution of β-catenin alters its nuclear translocation, thus
reducing transcriptional activation. In support of this view,
β-catenin aggregates have been observed in the brain of patients
and mice models of the neurodegenerative Huntington’s disease;
moreover, the silencing of β-catenin rescued neuronal degen-
eration in this model system (Godin et al., 2010), suggesting
that β-catenin aggregation could be crucial in the pathogenesis
of ALS.
Similar to Wnt pathway, BMP signaling is also altered in the
damaged adult nervous system (Wang et al., 2007; Bayat et al.,
2011). We found a strong induction of Id1, Smad phospho-
rylation and Smad-dependent transcription in undifferentiated
NSC34hSOD1G93A cells, suggesting that BMP signaling could
be up-regulated during early stages of the ALS condition. Inter-
estingly, the levels of the BMP2 ligand are up-regulated upon
induction of neuronal damage (Wang et al., 2007; Matsuura et al.,
2008). In this regard, we have recently demonstrated that activa-
tion of Smad-dependent signaling by treatment of NSC34 cells
with the BMP2 ligand correlates with decreased morphological
differentiation; however, it also induces the expression of the type
II BMP receptor, which could be required for subsequent steps of
regeneration (Benavente et al., 2012). In our ALS model system,
the decreased morphological differentiation that correlates with
up-regulation of Smad-dependent signaling was not accompanied
by changes in the expression of the type II BMP receptor. Simi-
larly, in Drosophila models of several motor diseases, including
ALS, signaling mediated by the BMPRII is impaired (Ratnaparkhi
et al., 2008; Hirth, 2010), thus suggesting that signaling through
this receptor could also play important roles on the pathogenesis
of ALS.
Altogether, our ﬁndings ﬁt with a model (Figure 8) where
signaling through Wnt and BMP morphogens act as potential
mediators of the pathogenesis of ALS, with opposite alterations
at different stages of development; whereas BMP/Smad signaling
could be up-regulated during early stages of the differentiation
of ALS motor neurons, the differentiated cells could display an
impaired ability to activate Wnt/β-catenin signaling. Remarkably,
cumulative evidence reveals that these two signaling pathways
interact in various developmental and tissue speciﬁc contexts
to exert many different cellular responses (Itasaki and Hoppler,
2010; Marcellini et al., 2012). Modulating these signaling path-
ways individually or in a coordinated fashion could then represent
interesting therapeutic alternatives to mitigate the progression
of ALS.
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